Literature DB >> 28219882

Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis.

Orit Schieir1, Cedomir Tosevski2, Richard H Glazier3, Sheilah Hogg-Johnson4, Elizabeth M Badley1,5.   

Abstract

OBJECTIVE: To synthesise, quantify and compare risks for incident myocardial infarction (MI) across five major types of arthritis in population-based studies.
METHODS: A systematic search was performed in MEDLINE, EMBASE and CINAHL databases with additional manual/hand searches for population-based cohort or case-control studies published in English of French between January 1980 and January 2015 with a measure of effect and variance for associations between incident MI and five major types of arthritis: rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), gout or osteoarthritis (OA), adjusted for at least age and sex. All search screening, data abstraction quality appraisals were performed independently by two reviewers. Where appropriate, random-effects meta-analysis was used to pool results from studies with a minimum of 10 events.
RESULTS: We identified a total of 4, 285 articles; 27 met review criteria and 25 criteria for meta-analyses. In studies adjusting for age and sex, MI risk was significantly increased in RA (pooled relative risk (RR): 1.69, 95% CI 1.50 to 1.90), gout (pooled RR: 1.47, 95% CI 1.24 to 1.73), PsA (pooled RR: 1.41, 95% CI 1.17 to 1.69), OA (pooled RR: 1.31, 95% CI 1.01 to 1.71) and tended towards increased risk in AS (pooled RR: 1.24, 95% CI 0.93 to 1.65). Traditional risk factors were more prevalent in all types of arthritis. MI risk was attenuated for each type of arthritis in studies adjusting for traditional risk factors and remained significantly increased in RA, PsA and gout.
CONCLUSIONS: MI risk was consistently increased in multiple types of arthritis in population-based studies, and was partially explained by a higher prevalence of traditional risk factors in all types of arthritis. Findings support more integrated cardiovascular (CV) prevention strategies for arthritis populations that target both reducing inflammation and enhancing management of traditional CV risk factors. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Arthritis; Cardiovascular Disease; Epidemiology

Mesh:

Year:  2017        PMID: 28219882     DOI: 10.1136/annrheumdis-2016-210275

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  41 in total

Review 1.  Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis.

Authors:  Anne Grete Semb; Eirik Ikdahl; Grunde Wibetoe; Cynthia Crowson; Silvia Rollefstad
Journal:  Nat Rev Rheumatol       Date:  2020-06-03       Impact factor: 20.543

2.  Prevalence of high-sensitivity cardiac troponin T in real-life cohorts of psoriatic arthritis and general population: a cross-sectional study.

Authors:  Victoria Furer; Shani Shenhar-Tsarfaty; Shlomo Berliner; Uri Arad; Daphna Paran; Inna Mailis; Ori Rogowski; David Zeltser; Itzhak Shapira; Hagit Matz; Ori Elkayam
Journal:  Rheumatol Int       Date:  2019-10-23       Impact factor: 2.631

Review 3.  Epidemiology of osteoarthritis: literature update.

Authors:  Ernest R Vina; C Kent Kwoh
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

Review 4.  Cardiovascular effects of approved drugs for rheumatoid arthritis.

Authors:  Fabiola Atzeni; Javier Rodríguez-Carrio; Călin D Popa; Michael T Nurmohamed; Gabriella Szűcs; Zoltán Szekanecz
Journal:  Nat Rev Rheumatol       Date:  2021-04-08       Impact factor: 20.543

Review 5.  Inflammaging and Osteoarthritis.

Authors:  Francesca Motta; Elisa Barone; Antonio Sica; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-18       Impact factor: 8.667

Review 6.  At the crossroads of gout and psoriatic arthritis: "psout".

Authors:  Renaud Felten; Pierre-Marie Duret; Jacques-Eric Gottenberg; Lionel Spielmann; Laurent Messer
Journal:  Clin Rheumatol       Date:  2020-02-15       Impact factor: 2.980

7.  Impaired arterial responsiveness in untreated gout patients compared with healthy non-gout controls: association with serum urate and C-reactive protein.

Authors:  Svetlana Krasnokutsky; Aaron Garza Romero; Daisy Bang; Virginia C Pike; Binita Shah; Talia F Igel; Irina Dektiarev; Yu Guo; Judy Zhong; Stuart D Katz; Michael H Pillinger
Journal:  Clin Rheumatol       Date:  2018-02-15       Impact factor: 2.980

8.  Transcription Factor MAFF (MAF Basic Leucine Zipper Transcription Factor F) Regulates an Atherosclerosis Relevant Network Connecting Inflammation and Cholesterol Metabolism.

Authors:  Moritz von Scheidt; Yuqi Zhao; Thomas Q de Aguiar Vallim; Nam Che; Michael Wierer; Marcus M Seldin; Oscar Franzén; Zeyneb Kurt; Shichao Pang; Dario Bongiovanni; Masayuki Yamamoto; Peter A Edwards; Arno Ruusalepp; Jason C Kovacic; Matthias Mann; Johan L M Björkegren; Aldons J Lusis; Xia Yang; Heribert Schunkert
Journal:  Circulation       Date:  2021-02-25       Impact factor: 29.690

9.  Cardiovascular events prediction by left ventricular longitudinal strain and serum high-sensitivity troponin I in patients with axial spondyloarthritis.

Authors:  Yan Chen; Yap-Hang Chan; Ho-Yin Chung; Mei-Zhen Wu; Yu-Juan Yu; Kang-Li Pi; Chak-Sing Lau; Hung-Fat Tse; Kai-Hang Yiu
Journal:  Clin Rheumatol       Date:  2020-05-13       Impact factor: 2.980

10.  Association of C-reactive protein and non-steroidal anti-inflammatory drugs with cardiovascular events in patients with psoriatic arthritis: a time-dependent Cox regression analysis.

Authors:  Steven H Lam; Ho So; Isaac T Cheng; Edmund K Li; Priscilla Wong; Tena K Li; Alex Pui-Wai Lee; Lai-Shan Tam
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-06-30       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.